Thirty years after its discovery, scientists are eyeing leptin with renewed interest, for everything from weight loss drug ...

In South Africa, access to weight loss medicines like Ozempic and Mounjaro remains limited to those who can shell out a few thousand rand a month.

The GLP-1 revolution is reshaping obesity care, revealing how primary care economics and reimbursement gaps leave patients ...

Septerna is poised for a pivotal catalyst with upcoming Phase 1 data for SEP-631, targeting mast cell-driven diseases via ...

Novo Nordisk is suing a Shrewsbury doctor who sells a cheaper compounded medicine version of its popular Ozempic and Wegovy weight-loss drugs.

The price of the popular GLP-1 medications will be cut, starting in January of 2027, manufacturer Novo Nordisk said in a ...

Drugmaker Novo Nordisk plans to slash list prices for its wildly popular weight-loss and diabetes drugs Wegovy and Ozempic by ...

These patients, who may have high-deductible health plans or co-insurance, will be able to purchase both the pill and injection forms of obesity treatment Wegovy, the Ozempic diabetes shot, and oral ...

Retatrutide targets metabolism, appetite, and energy expenditure, promising impressive results. Clinical trials are being ...

GP practices in England are to be paid an average of £3,000 a year in bonuses to prescribe patients weight loss drugs. The government is adding the incentive payments to the GP contract starting in ...

"I came home one night and rushed into it," she says. "I typed in 'weight-loss injections'. I just wanted to lose weight as quickly as I could. I thought if I was skinny again, people would accept me ...